About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prospective Memory in Parkinson's Disease

NCT00913640·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Washington University School of Medicine

With

National Institutes of Health (NIH)

Age

40–70

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

PD Group:
* Clinically definite PD
* 40-70 years old
* Hoehn and Yahr stage I,II,III
* Currently treated with Levodopa/carbidopa
Control Group:
* 40-70 years old
* Spouses of PD Group preferred

You may not be if

PD Group and Control Group:
* Significant neurological problems
* Significant current psychiatric diagnoses
* Mini Mental Status Exam score \< 24 (MMSE)
* Any significant abnormality on brain imaging
* MPTP exposure

The record

StatusCompleted

PhaseNo phase

Taking part52

StartedNov 2009

UpdatedMay 6, 2022

Conditions

Memory Prospective Memory Parkinson's Disease

Where1

Washington University School of Medicine
St Louis, Missouri, United States

Clareo Health | Prospective Memory in Parkinson's Disease